T1	Participants 47 93	previously untreated advanced breast cancer--a
T2	Participants 624 678	previously untreated metastatic breast cancer patients
T3	Participants 1232 1336	Patients had to have histologically documented measurable breast cancer and a performance status of 0-1.
T4	Participants 1337 1407	Patients could not have had prior chemotherapy for metastatic disease.
T5	Participants 1408 1450	Prior adjuvant chemotherapy was permitted.
T6	Participants 1451 1491	Patients could not have visceral crisis.
T7	Participants 2226 2270	previously untreated breast cancer patients.
